Survey for asymptomatic malaria cases in low transmission settings of Iran under elimination programme

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Zoghi, Samaneh ^a   Mehrizi, Akram A ^a   Raeisi, Ahmad ^b   Haghdoost, Ali A ^c   Turki, Habibollah ^d   Safari, Reza ^d   Kahanali, Asadallah Ahmadi ^e   Zakeri, Sedigheh ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d HORMOZGAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e JIROFT UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 2; PARASITE ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ARTICLE; ASYMPTOMATIC INFECTION; BLOOD SMEAR; CHILD; CONTROLLED STUDY; DISEASE CARRIER; FEMALE; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INTERVIEW; IRAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MICROSCOPY; NUCLEOTIDE SEQUENCE; PARASITE TRANSMISSION; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; SCHOOL CHILD; SEROPREVALENCE; ZOONOSIS;

ADOLESCENT; ADULT; ASYMPTOMATIC DISEASES; BLOOD; CARRIER STATE; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DISEASE ERADICATION; ENDEMIC DISEASES; FEMALE; HUMANS; IRAN; MALARIA, FALCIPARUM; MALARIA, VIVAX; MALE; MICROSCOPY; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; PREVALENCE; YOUNG ADULT;

EID: 84862193570     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-126     Document Type: Article

References (44)

1. The role of variant-specific immunity in asymptomatic malaria infections: maintaining a fine balance. Staalsoe T, Hviid L, Parasitol Today 1998 14 177 178 10.1016/S0169-4758(98)01228-9 17040744
2. Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya. Bousema JT, Gouagna LC, Drakeley CJ, Meutstege AM, Okech BA, Akim IN, Beier JC, Githure JI, Sauerwein RW, Malar J 2004 3 18 10.1186/1475-2875-3- 18 15202944
3. Exploring the relationship between chronic undernutrition and asymptomatic malaria in Ghanaian children. Crookston BT, Alder SC, Boakye I, Merrill RM, Amuasi JH, Porucznik CA, Stanford JB, Dickerson TT, Dearden KA, Hale DC, Sylverken J, Snow BS, Osei-Akoto A, Ansong D, Malar J 2010 9 39 10.1186/1475-2875-9-39 20122258
4. Incidence of symptomatic and asymptomatic Plasmodium falciparum infection following curative therapy in adult residents of Northern Ghana. Owusu-Agyei S, Koram KA, Baird JK, Utz GC, Binka FN, Nkrumah FK, Fryauff DJ, Hoffman SL, Am J Trop Med Hyg 2001 65 197 203 11561704
5. Long-term asymptomatic carriage of Plasmodium falciparum protects from malaria attacks: a prospective study among SeneGhalese children. Males S, Gaye O, Garcia A, Clin Infect Dis 2008 46 516 522 10.1086/526529 18199040
6. Relation between Plasmodium falciparum asymptomatic infection and malaria attacks in a cohort of SeneGhalese children. Le Port A, Cot M, Etard JF, Gaye O, Migot-Nabias F, Garcia A, Malar J 2008 7 193 10.1186/1475-2875-7-193 18823542
7. Malaria and asymptomatic parasitaemia in Gabonese infants under the age of 3months. Klein Klouwenberg PM, Oyakhirome S, Schwarz NG, Glser B, Issifou S, Kiessling G, Klpfer A, Kremsner PG, Lngin M, Lassmann B, Necek M, Ptschke M, Ritz A, Grobusch MP, Acta Trop 2005 95 81 85 10.1016/j.actatropica.2005.05.003 15950165
8. Prevalence of Plasmodium falciparum infection in asymptomatic rural Gabonese populations. Nkoghe D, Akue JP, Gonzalez JP, Leroy EM, Malar J 2011 10 33 10.1186/1475-2875-10-33 21306636
9. High prevalence of asymptomatic Plasmodium infection in a suburb of Aba Town, Nigeria. Eke RA, Chigbu LN, Nwachukwu W, Ann of Afr Med 2006 5 42 45
10. Asymptomatic malaria parasitaemia and seroreactivities to Plasmodium falciparum antigens in blood donors from Ibadan, south-western Nigeria. Achidi EA, Perlmann H, Berzins K, Ann Trop Med Parasitol 1995 89 601 610 8745935
11. Asymptomatic parasitaemia as a risk factor for symptomatic malaria in a cohort of Ugandan children. Njama-Meya D, Kamya MR, Dorsey G, Trop Med Int Health 2004 9 862 868 10.1111/j.1365-3156.2004.01277.x 15303990
12. Comparison of field and expert laboratory microscopy for active surveillance for asymptomatic Plasmodium falciparum and Plasmodium vivax in western Thailand. Coleman RE, Maneechai N, Rachaphaew N, Kumpitak C, Miller RS, Soyseng V, Thimasarn K, Sattabongkot J, Am J Trop Med Hyg 2002 67 141 144 12389937
13. Prevalence of Plasmodium falciparum in active conflict areas of eastern Burma: a summary of cross-sectional data. Richards AK, Smith L, Mullany LC, Lee CI, Whichard E, Banek K, Mahn M, ShweOo EK, Lee TJ, Confl Health 2007 1 9 10.1186/1752-1505-1-9 17803819
14. Malaria signs and infection rate among asymptomatic schoolchildren in Hajr Valley, Yemen. Bin Mohanna MA, Bin Ghouth AS, Rajaa YA, East Mediterr Health J 2007 13 35 40 17546903
15. The epidemiology of malaria in an epidemic area of the Peruvian Amazon. Roper MH, Torres RS, Goicochea CG, Andersen EM, Guarda JS, Calampa C, Hightower AW, Magill AJ, Am J Trop Med Hyg 2000 62 247 256 10813480
16. High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian populations. Alves FP, Durlacher RR, Menezes MJ, Krieger H, Silva LH, Camargo EP, Am J Trop Med Hyg 2002 66 641 648 12224567
17. Endemic malaria in the Peruvian Amazon region of Iquitos. Roshanravan B, Kari E, Gilman RH, Cabrera L, Lee E, Metcalfe J, Calderon M, Lescano AG, Montenegro SH, Calampa C, Vinetz JM, Am J Trop Med Hyg 2003 69 45 52 12932096
18. Cross-sectional study defines difference in malaria morbidity in two Yanomami communities on Amazonian boundary between Brazil and Venezuela. Marcano TJ, Morgado A, Tosta CE, Coura JR, Mem Inst Oswaldo Cruz 2004 99 369 376 10.1590/S0074-02762004000400005 15322625
19. Clustered local transmission and asymptomatic Plasmodium falciparum and Plasmodium vivax malaria infections in a recently emerged, hypoendemic Peruvian Amazon community. Branch O, Casapia WM, Gamboa DV, Hernandez JN, Alava FF, Roncal N, Alvarez E, Perez EJ, Gotuzzo E, Malar J 2005 4 27 10.1186/1475-2875-4- 27 15975146
20. Epidemiologic aspects of the malaria transmission cycle in an area of very low incidence in Brazil. Cerutti C, Boulos M, Coutinho AF, HatabMdo C, Falqueto A, Rezende HR, Duarte AM, Collins W, Malafronte RS, Malar J 2007 6 33 10.1186/1475-2875-6-33 17371598
21. Molecular screening of Plasmodium spp. asymptomatic carriers among transfusion centers from Brazilian Amazon region. Fugikaha E, Fornazari PA, Penhalbel Rde S, Lorenzetti A, Maroso RD, Amoras JT, Saraiva AS, Silva RU, Bonini-Domingos CR, Mattos LC, Rossit AR, Cavasini CE, Machado RL, Rev Inst Med Trop Sao Paulo 2007 49 1 4 17384812
22. Urban and suburban malaria in Rondnia (Brazilian Western Amazon) II. Perennial transmissions with high anopheline densities are associated with human environmental changes. Gil LH, Tada MS, Katsuragawa TH, Ribolla PE, da Silva LH, Mem Inst Oswaldo Cruz 2007 102 271 276 10.1590/S0074-02762007005000013 17568931
23. Cross sectional study reveals a high percentage of asymptomatic Plasmodium vivax infection in the Amazon Rio Negro area, Brazil. Surez-Mutis MC, Cuervo P, Leoratti FM, Moraes-Avila SL, Ferreira AW, Fernandes O, Coura JR, Rev Inst Med Trop Sao Paulo 2007 49 159 164 17625693
24. Asymptomatic Plasmodium spp. infection in Tierralta, Colombia. Cucunub ZM, Guerra AP, Rahirant SJ, Rivera JA, Corts LJ, Nicholls RS, Mem Inst Oswaldo Cruz 2008 103 668 673 19057816
25. A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting. Harris I, Sharrock WW, Bain LM, Gray KA, Bobogare A, Boaz L, Lilley K, Krause D, Vallely A, Johnson ML, Gatton ML, Shanks GD, Cheng Q, Malar J 2010 9 254 10.1186/1475-2875-9-254 20822506
26. Pre-elimination of malaria on the island of Prncipe. Lee PW, Liu CT, Rampao HS, do Rosario VE, Shaio MF, Malar J 2010 9 26 10.1186/1475-2875-9-26 20089158
27. Possible interruption of malaria transmission, highland Kenya, 20072008. John CC, Riedesel MA, Magak NG, Lindblade KA, Menge DM, Hodges JS, Vulule JM, Akhwale W, Infect Dis 2009 15 1917 1924
28. Absence of asymptomatic malaria infections in previously high endemic areas of Sri Lanka. Fernando SD, Abeyasinghe RR, Galappaththy GN, Rajapaksa LC, Am J Trop Med Hyg 2009 81 763 767 10.4269/ajtmh.2009.09-0042 19861607
29. Malaria in Iran: past and present situation. Edrissian GhH, Irainian J Parasitol 2006 1 1 14
30. Cohen JM, Smith DL, Vallely A, Taleo G, Sabot O, Holding the line. Shrinking the malaria map: a prospectus on malaria elimination The Global Health Group, 2009 40 60
31. WHO, World Malaria Report 2008 World Health Organization, Geneva, Switzerland http://malaria.who.int/wmr2008/malaria2008.pdf
32. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN, Mol Biochem Parasitol 1993 58 283 292 10.1016/0166-6851(93)90050-8 8479452
33. Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria. Soares IS, Levitus G, Souza JM, Del Portillo HA, Rodrigues MM, Infect Immun 1997 65 1606 1614 9125537
34. Longevity of naturally acquired antibody responses to the N- andC-terminal regions of Plasmodium vivax merozoite surface protein 1. Soares IS, da Cunha MG, Silva MN, Souza JM, Dell Portillo HA, Rodrigues MM, Am J Trop Med Hyg 1999 60 357 363 10466961
35. IgG subclasses pattern and high-avidity antibody to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in an unstable hypoendemic region in Iran. Mehrizi AA, Zakeri S, Salmanian AH, Sanati MH, Djadid ND, Acta Trop 2009 112 1 7 10.1016/j.actatropica.2009.05.016 19481997
36. Non-variant specific antibody responses to the C-terminal region of merozoite surface protein-1 of Plasmodium falciparum (PfMSP-1(19)) in Iranians exposed to unstable malaria transmission. Zakeri S, Mehrizi AA, Zoghi S, Djadid ND, Malar J 2010 9 257 10.1186/1475-2875-9-257 20846388
37. Recent primary Toxoplasma infection indicated by a low avidity of specific IgG. Hedman K, Lappalainen M, Seppaia I, Makela O, J Infect Dis 1989 159 736 740 10.1093/infdis/159.4.736 2926163
38. Submicroscopic infection in Plasmodium falciparum-endemic populations: a systematic review and meta-analysis. Okell LC, Ghani AC, Lyons E, Drakeley CJ, J Infect Dis 2009 200 1509 17 10.1086/644781 19848588
39. Serology: a robust indicator of malaria transmission intensity? Corran P, Coleman P, Riley E, Drakeley C, Trends Parasitol 2007 23 575 82 10.1016/j.pt.2007.08.023 17988945
40. Potential contribution of sero-epidemiological analysis for monitoring malaria control and elimination: historical and current perspectives. Drakeley C, Cook J, Adv Parasitol 2009 69 299 352 19622411
41. Using serological measures to monitor changes in malaria transmission in Vanuatu. Cook J, Reid H, Iavro J, Kuwahata M, Taleo G, Clements A, McCarthy J, Vallely A, Drakeley C, Malar J 2010 9 169 10.1186/1475-2875-9-169 20553604
42. Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. Drakeley CJ, Corran PH, Coleman PG, Tongren JE, McDonald SL, Carneiro I, Malima R, Lusingu J, Manjurano A, Nkya WM, Lemnge MM, Cox J, Reyburn H, Riley EM, Proc Natl Acad Sci U S A 2005 102 5108 5113 10.1073/pnas.0408725102 15792998
43. Application of anti-Toxoplasma IgG antibodies avidity test. Frota C, Fontes E, Bichat R, Fernandes O, J Bras Pat Med Lab 2001 37 98 99
44. IgG subclass antibodies to three variants of Plasmodium falciparum merozoite surface protein-1 (PfMSP-1(19)) in an area with unstable malaria transmission in Iran. Mehrizi AA, Asgharpour S, Salmanian AH, Djadid ND, Zakeri S, Acta Trop 2011 119 84 90 10.1016/j.actatropica.2011.04.012 21609709